glp-1 agonist mechanism of action of [25] Outpatient Sedation Basics for Patients

Significantly, among suboptimally controlled GLP-1RA users, the vast majority received treatment intensification (almost 89.0%), whereas, worryingly, among non-GLP-1 users, nearly half did not receive treatment intensification during follow-up

The main concerns with GLP-1 agonist drugs include: GI side effects (nausea, diarrhea, vomiting, constipation, abdominal pain) High out-of-pocket cost for those who do not quality under insurance Risk of inadequate nutrition (reduced intake + insufficient nutrition counseling) Significant loss of muscle mass & bone density High discontinuation rates (with lost weight regained) Limited public & clinician knowledge on importance/implementation of nutrition and lifestyle changes Side Effects and Costs of GLP-1 Medications The use of GLP-1 drugs has been associated with numerous side effects, ranging from mild to severe

There have been several head-to-head clinical trials comparing the efficacy of different GLP-1 receptor agonists broadly demonstrating the superiority of semaglutide to comparators [37]

Alcohol use A patient with a history of excess alcohol use must be advised to stop consuming alcohol before starting GLP-1 receptor agonist therapy

The physiological role of the brain GLP-1 system in stress

Beyond glucose control, GLP-1 significantly affects satiety and gastric function